Company Spotlight

Aphena Pharma Solutions, Inc.

1920 Fisk Road
Cookeville, TN 38506
United States
View Profile

Adare Pharmaceuticals

1200 Lenox Drive
Princeton Pike Corporate Center, Suite 100
Lawrence Township, NJ 08648
United States
View Profile

Alcami

4620 Creekstone Drive
Durham, NC 27703
United States
View Profile


Contract Service Directory


Grifols International, S.A.





Company Headquarters

152 Avinguda de la Generalitat
Sant Cugat del Vallès, CT 08174
Spain

Company Description

Grifols Partnership is a business to business contract development and manufacturing platform (CDMO) for sterile solutions and lipid emulsions for the pharmaceutical industry. We specialize in small molecule intravenous solutions and offer high quality pharmaceutical development and product manufacturing. 75 years’ experience in producing intravenous solutions makes Grifols Partnership a reliable and efficient partner for your contract manufacturing needs. We offer the human or veterinary pharmaceutical industry sterile solutions and lipid emulsions in glass vials and polypropylene bags. Strict compliance with global manufacturing standards has earned us the highest accreditations, including authorizations by the US FDA, EU and US GMP and authorization for parametric release sterility. Grifols Partnership works together with customers from the early stages of development until commercial manufacturing to provide our customers with a fast and efficient service.

Contract Service Directory

    Related Content

    • Breaking News | CRO News | Promotions & Moves
      Parexel Adds Experts to Regulatory Consulting Group

      Parexel Adds Experts to Regulatory Consulting Group

      Four new hires from U.S. FDA and MHRA will serve as technical vice presidents
      12.10.19

    • Breaking News | Drug Development | Trials & Filings
      SK Bio Gains FDA Approval for XCOPRI

      SK Bio Gains FDA Approval for XCOPRI

      Marks the first time a Korean company has independently brought a compound from discovery to U.S. FDA approval
      11.25.19

    • Breaking News | Collaborations & Alliances | Drug Development | Trials & Filings
      Roche’s Risdiplam for SMA Granted Priority Review

      Roche’s Risdiplam for SMA Granted Priority Review

      FDA filing triggers $15M milestone to development partner PTC Therapeutics
      11.25.19


    • Biologics, Proteins, Vaccines | Biosimilars
      Biopharma Over 20 Years

      Biopharma Over 20 Years

      A look at the key trends that have impacted the biopharma industry over the years.
      K. John Morrow, Jr. and Eric S. Langer, BioPlan Associates 11.20.19

    • cGMP Manufacture | Drug Development
      Contract Pharma’s 20th Anniversary Series: Catalent

      Contract Pharma’s 20th Anniversary Series: Catalent

      Elliott Berger of Catalent shares his insights on the past 20 years and what we can anticipate for the future of the industry and outsourcing
      Kristin Brooks, Contract Pharma 11.08.19

    • Keynote: FDA’s Continuous Manufacturing Journey: Past, Present and Future

      Tuesday, November 5th, 1:30 PM - 2:30 PM   Keynote: FDA’s Continuous Manufacturing Journey: Past, Present and Future Location: 214 CD Manufacturing and Bioprocessing – Chemical…
      10.28.19


    • Clinical Trial Materials
      Overcoming the Small Molecule Bioavailability Challenge

      Overcoming the Small Molecule Bioavailability Challenge

      Approximately 90% of preclinical compounds are estimated to face bioavailability challenges.
      David Lyon, Sr. Research Fellow, Lonza Pharma & Biotech 10.15.19

    • APIs | Cytotoxics and High Potency Manufacturing | Facilities
      Flamma Arrives in the U.S.

      Flamma Arrives in the U.S.

      Italian CDMO sets down roots in the U.S. market with purchase of Teva facility.
      Tim Wright, Editor, Contract Pharma 10.15.19

    • Bio News | Breaking News | Industry News | Promotions & Moves
      AGC Biologics Bolsters Denmark Operations

      AGC Biologics Bolsters Denmark Operations

      Jeffrey D. Mowery named site head/general manager of Copenhagen facility
      10.04.19


    • Bioanalytical Services | Biologics, Proteins, Vaccines | Industry News | Laboratory Testing
      Frontage Expands Bioanalytical Capacity and Capabilities

      Frontage Expands Bioanalytical Capacity and Capabilities

      To add 10,000 square feet of lab space to support biologic drug development, biomarkers and cell and gene therapy
      10.03.19

    • Bioanalytical Services | CRO News | Laboratory Testing
      PPD Expands Bioanalytical Lab in Richmond, VA

      PPD Expands Bioanalytical Lab in Richmond, VA

      The expansion includes growing the lab’s immunochemistry and biomarker space by 8,000 square feet
      09.19.19

    • PPD Expands Bioanalytical Lab Capabilities

      PPD Expands Bioanalytical Lab Capabilities

      Expansion includes growing the lab’s immunochemistry and biomarker space by 8,000 square feet
      09.19.19


    • Contracting And Outsourcing Exhibitor List

      2019 Exhibitors Company Table 3C PACKAGING 138 Adare Pharmaceuticals 97 Adents 123 Admix Pharma Labs 135 Advanced Analytical…
      09.17.19

    • Regulatory Affairs
      Quality Metrics Feedback

      Quality Metrics Feedback

      A look at FDA’s Quality Metrics Initiative, a complicated issue for all of pharma stakeholders
      Gil Roth, President, Pharma & Biopharma Outsourcing Association 09.16.19

    • Breaking News | Clinical Trials | Industry News | Inspections | QA/QC
      FDA Extends CRADA with CluePoints

      FDA Extends CRADA with CluePoints

      Aims to further explore a data-driven approach to quality oversight in clinical trials
      09.11.19

    • cGMP Manufacture | Collaborations & Alliances
      NIIMBL, FDA to Advance Innovation in Bio Manufacturing

      NIIMBL, FDA to Advance Innovation in Bio Manufacturing

      CRADA enables FDA and NIIMBL to support investments in regulatory science research, and training needed to foster advanced manufacturing innovations
      08.01.19

    • Trials & Filings
      FDA Accepts RedHill Biopharma’s NDA for Talicia

      FDA Accepts RedHill Biopharma’s NDA for Talicia

      Commercial launch of H. pylori treatment is planned shortly following potential FDA approval
      07.16.19

    • Extractables and Leachables | Laboratory Testing
      The FDA Gets Stricter with E&L Oversight, Can the Industry Keep Up?

      The FDA Gets Stricter with E&L Oversight, Can the Industry Keep Up?

      Andrew Kolbert of Avomeen discusses FDA oversight of E&L testing, complications that arise, and the expertise needed to keep up with changing quality standards
      Kristin Brooks, Contract Pharma 07.11.19

    • APIs | Breaking News | Industry News
      Regis Technologies Expands Capabilities

      Regis Technologies Expands Capabilities

      CDMO now offering solid state chemistry services
      07.03.19

    • APIs | Breaking News | Facilities | Industry News
      FLAMMA Acquires Teva’s Philadelphia cGMP Facility

      FLAMMA Acquires Teva’s Philadelphia cGMP Facility

      Marks entry into the U.S. marketplace with labs & pilot plant
      07.01.19

    • Trials & Filings
      Sierra’s Momelotinib Granted FDA Fast Track Designation

      Sierra’s Momelotinib Granted FDA Fast Track Designation

      Underscores potential for momelotinib to address unmet needs of patients with Intermediate/High-Risk myelofibrosis who have previously received a JAK inhibitor
      06.19.19